Extracellular Vesicles in Diffuse Large B Cell Lymphoma: Characterization and Diagnostic Potential.

Area of Science:

• Oncology
• Biochemistry
• Proteomics

Background:

• Diffuse large B cell lymphoma (DLBCL) is an aggressive hematologic malignancy with heterogeneous behavior.
• Accurate biological characterization, monitoring, and prognostic tools are needed for DLBCL management.
• Extracellular vesicles (EVs) reflect their cell of origin and are potential biomarkers.

Purpose of the Study:

• To characterize and evaluate the diagnostic and prognostic potential of plasma extracellular vesicle (EV) proteome in DLBCL.
• To identify EV proteins that can differentiate DLBCL patients from healthy individuals.
• To explore the correlation of EV proteins with DLBCL subtypes and patient survival.

Main Methods:

• Plasma extracellular vesicles (EVs) were isolated from DLBCL patients and healthy donors.
• EV proteome was analyzed using state-of-the-art mass spectrometry.
• Bioinformatic and statistical analyses were performed for classification, subtype correlation, and survival analysis.

Main Results:

• The EV proteome significantly differs between DLBCL patients and healthy donors, with multiple unique proteins identified.
• A proof-of-concept classifier achieved perfect accuracy (sensitivity and specificity of 1) in distinguishing DLBCL.
• Multiple EV proteins were significantly correlated with patient survival, indicating prognostic potential.

Conclusions:

• The plasma EV proteome serves as a reliable biomarker for identifying DLBCL cancer patients.
• EV proteins hold significant potential as biomarkers for predicting survival in DLBCL patients.
• While EV proteome did not significantly differentiate GCB and non-GCB subtypes, functional analysis suggested altered antigen binding.